Literature DB >> 24721654

Targeting sodium channels in cardiac arrhythmia.

Carol Ann Remme1, Arthur A M Wilde2.   

Abstract

Cardiac voltage-gated sodium channels are responsible for proper electrical conduction in the heart. During acquired pathological conditions and inherited sodium channelopathies, altered sodium channel function causes conduction disturbances and ventricular arrhythmias. Although the clinical, genetic and biophysical characteristics of cardiac sodium channel disease have been extensively studied, limited progress has been made in the development of treatment strategies targeting sodium channels. Classical non-selective sodium channel blockers have only limited clinical applicability, while more selective inhibitors of the late sodium current constitute a more promising treatment option. Because of our insufficient understanding of their complexity and subcellular diversity, other specific therapeutic targets for modulating sodium channels remain elusive. The current status and future potential of targeting sodium channels in cardiac arrhythmias are discussed.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24721654     DOI: 10.1016/j.coph.2013.11.014

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  13 in total

1.  The citrus flavanone hesperetin preferentially inhibits slow-inactivating currents of a long QT syndrome type 3 syndrome Na+ channel mutation.

Authors:  Julio Alvarez-Collazo; Alejandro López-Requena; Loipa Galán; Ariel Talavera; Julio L Alvarez; Karel Talavera
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

Review 2.  The cardiac sodium channel gene SCN5A and its gene product NaV1.5: Role in physiology and pathophysiology.

Authors:  Christiaan C Veerman; Arthur A M Wilde; Elisabeth M Lodder
Journal:  Gene       Date:  2015-09-08       Impact factor: 3.688

Review 3.  Physiologic and pathophysiologic consequences of altered sialylation and glycosylation on ion channel function.

Authors:  Deniz Baycin-Hizal; Allan Gottschalk; Elena Jacobson; Sunny Mai; Daniel Wolozny; Hui Zhang; Sharon S Krag; Michael J Betenbaugh
Journal:  Biochem Biophys Res Commun       Date:  2014-06-24       Impact factor: 3.575

4.  Gating pore currents are defects in common with two Nav1.5 mutations in patients with mixed arrhythmias and dilated cardiomyopathy.

Authors:  Adrien Moreau; Pascal Gosselin-Badaroudine; Lucie Delemotte; Michael L Klein; Mohamed Chahine
Journal:  J Gen Physiol       Date:  2015-02       Impact factor: 4.086

5.  Changes in Intracellular Na+ following Enhancement of Late Na+ Current in Virtual Human Ventricular Myocytes.

Authors:  Karen Cardona; Beatriz Trenor; Wayne R Giles
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

Review 6.  Cav1.3 Channels as Key Regulators of Neuron-Like Firings and Catecholamine Release in Chromaffin Cells.

Authors:  David H F Vandael; Andrea Marcantoni; Emilio Carbone
Journal:  Curr Mol Pharmacol       Date:  2015       Impact factor: 3.339

7.  Antiarrhythmic Properties of Elsholtzia ciliata Essential Oil on Electrical Activity of the Isolated Rabbit Heart and Preferential Inhibition of Sodium Conductance.

Authors:  Regina Mačianskienė; Lauryna Pudžiuvelytė; Jurga Bernatonienė; Mantė Almanaitytė; Antanas Navalinskas; Rimantas Treinys; Inga Andriulė; Jonas Jurevičius
Journal:  Biomolecules       Date:  2020-06-23

Review 8.  Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview.

Authors:  Guihua Tian; Yang Sun; Shuo Liu; Chengyu Li; Shiqi Chen; Ruijin Qiu; Xiaoyu Zhang; Youping Li; Min Li; Hongcai Shang
Journal:  Front Pharmacol       Date:  2018-09-05       Impact factor: 5.810

9.  Absence of Functional Nav1.8 Channels in Non-diseased Atrial and Ventricular Cardiomyocytes.

Authors:  Simona Casini; Gerard A Marchal; Makiri Kawasaki; Fransisca A Nariswari; Vincent Portero; Nicoline W E van den Berg; Kaomei Guan; Antoine H G Driessen; Marieke W Veldkamp; Isabella Mengarelli; Joris R de Groot; Arie O Verkerk; Carol Ann Remme
Journal:  Cardiovasc Drugs Ther       Date:  2019-12       Impact factor: 3.727

Review 10.  Therapeutic Approaches to Genetic Ion Channelopathies and Perspectives in Drug Discovery.

Authors:  Paola Imbrici; Antonella Liantonio; Giulia M Camerino; Michela De Bellis; Claudia Camerino; Antonietta Mele; Arcangela Giustino; Sabata Pierno; Annamaria De Luca; Domenico Tricarico; Jean-Francois Desaphy; Diana Conte
Journal:  Front Pharmacol       Date:  2016-05-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.